Parkinson's Disease Trial, Not Yet Recruiting NCT06473428 Sponsor: National Taiwan University Hospital Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Not Yet Recruiting

NCT06473428
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People diagnosed with Parkinson's disease at an early to mid stage (known as Hoehn & Yahr stage I–III).
  • People between the ages of 30 and 85.
  • People whose overall health condition is stable, who take their medications consistently, and who are able to follow instructions.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have problems with memory or thinking (cognitive impairment).
  • People who have a breathing condition or another neurological (brain or nerve) disease in addition to Parkinson's.
  • People who have a history of smoking.
  • People who have complications affecting their breathing or lungs.
  • People who have had surgery on their chest or abdomen recently.
  • People whose health condition is not considered stable at the time of the trial.
  • People who are unable to correctly perform breathing tests (pulmonary function tests).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 30 June 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 July 2024
Est. completion
30 June 2026

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Primary endpoints

Forced Vital Capacity (FVC); Forced Expiratory Volume in One Second (FEV1); Maximal Inspiratory Pressure (MIP); Maximal Expiratory Pressure (MEP); Peak Expiratory Flow Rate (PEFR); Maximum Phonation Time; Voice Intensity; Speech Rate; Speech Pauses; Voice Loudness; Voice Handicap Index (VHI-10)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov